Jack Brownrigg

Senior Director, Early Clinical Development at BioMarin Pharmaceutical

Jack Brownrigg, with a strong background in medical and pharmaceutical fields, has held various leadership positions in companies like BioMarin Pharmaceutical Inc., Pfizer, and London et al Scientific Communications Ltd. Jack has also contributed to research and academia as the Head of Research at Capital Cell and as a Specialty Registrar at St George's, University of London. Jack's educational qualifications include a Ph.D. in CV outcomes in diabetes from St George's, University of London, and a Bachelor of Medicine, Bachelor of Surgery (MBBS) from The University of Manchester.

Links

Org chart

Timeline

  • Senior Director, Early Clinical Development

    March 1, 2024 - present

  • Clinical Development Team Lead, Clinical Sciences

    February, 2022

  • Director, Clinical Sciences - Gene Therapy

    September, 2021

View in org chart